Abstract

Purine nucleotides are necessary for various biological processes related to cell proliferation. Despite their importance in DNA and RNA synthesis, cellular signaling, and energy-dependent reactions, the impact of changes in cellular purine levels on cell physiology remains poorly understood. Here, we find that purine depletion stimulates cell migration, despite effective reduction in cell proliferation. Blocking purine synthesis triggers a shunt of glycolytic carbon into the serine synthesis pathway, which is required for the induction of cell migration upon purine depletion. The stimulation of cell migration upon a reduction in intracellular purines required one-carbon metabolism downstream of de novo serine synthesis. Decreased purine abundance and the subsequent increase in serine synthesis triggers an epithelial-mesenchymal transition (EMT) and, in cancer models, promotes metastatic colonization. Thus, reducing the available pool of intracellular purines re-routes metabolic flux from glycolysis into de novo serine synthesis, a metabolic change that stimulates a program of cell migration.

Nucleotides are essential for different biological processes and have been also associated to cancer development. Depleting cellular nucleotides is a strategy commonly employed to target cancers. Here, the authors show that purine depletion induces serine synthesis to promote cancer cell migration and metastasis.

Details

Title
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway
Author
Soflaee, Mona Hoseini 1 ; Kesavan Rushendhiran 1   VIAFID ORCID Logo  ; Sahu Umakant 2 ; Tasdogan Alpaslan 3   VIAFID ORCID Logo  ; Villa Elodie 2 ; Zied, Djabari 2 ; Cai, Feng 1 ; Tran, Diem H 1   VIAFID ORCID Logo  ; Vu, Hieu S 1 ; Ali, Eunus S 2   VIAFID ORCID Logo  ; Halie, Rion 1 ; O’Hara Brendan P 2 ; Sherwin, Kelekar 1 ; Hallett James Hughes 4 ; Martin, Misty 1 ; Mathews, Thomas P 1 ; Gao, Peng 5   VIAFID ORCID Logo  ; Asara John M 6 ; Manning, Brendan D 4   VIAFID ORCID Logo  ; Ben-Sahra Issam 2   VIAFID ORCID Logo  ; Hoxhaj Gerta 1   VIAFID ORCID Logo 

 University of Texas Southwestern Medical Center, Children’s Medical Center Research Institute, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121) 
 Feinberg School of Medicine, Northwestern University, Department of Biochemistry and Molecular Genetics, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507); Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 University Hospital Essen & German Cancer Consortium, Partner Site, Department of Dermatology, Essen, Germany (GRID:grid.410718.b) (ISNI:0000 0001 0262 7331) 
 Harvard T. H. Chan School of Public Health, Department of Molecular Metabolism, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Metabolomics Core Facility, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507) 
 Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, USA (GRID:grid.239395.7) (ISNI:0000 0000 9011 8547) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2664961808
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.